TippingPoint

Tipping Point Biosciences

This biotechnology company develops a drug discovery platform and small molecule therapies targeting dysfunctional DNA packaging for patients with cancer and neurodegenerative diseases.

Talus Bio

The company develops a drug discovery platform that identifies transcription factor modulators for pharmaceutical and biotechnology partners seeking to treat cancers and other diseases.

Epitome Therapeutics

This biotechnology firm develops an epigenome editing platform for programmable gene expression to treat patients with rare genetic and metabolic disorders.

Dewpoint Therapeutics

This biotechnology company develops condensate-modifying small molecule drugs for patients with oncology, neurodegenerative, cardiopulmonary and metabolic diseases using an AI-enabled discovery platform.

Typewriter Therapeutics

The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.

Bullseye Biosciences

The company develops a drug discovery platform using robotics and directed evolution to create medicines for oncology, immunology and cardiometabolic diseases.

Stipple Bio

Stipple Bio develops a platform for mapping tumour-specific epitopes to create precision oncology medicines and antibody-drug conjugates for cancer patients.

Vividion

The company develops small-molecule medicines for patients with cancer and immune disorders using a proprietary chemoproteomics platform to target previously undruggable proteins.